Q2 2025 Earnings Call Transcript July 31, 2025 Amicus Therapeutics, Inc. misses on earnings expectations. Reported EPS is ...

Hemostemix (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is excited to highlight a groundbreaking ...

When most veterinarians hear the term "stem cell therapy," their minds often go to autologous procedures – tissue harvested ...

This study offers useful findings demonstrating the cartilage-protective effects of osteoactivin in inflammatory experimental models. The study provides compelling evidence that osteoactivin may serve ...

Cardiovascular diseases (CVDs) are the leading cause of mortality worldwide. About 17.9 million people died from CVDs in 2019 ...